Govt to develop playbook for surveillance and research of non-communicable diseases (NCDs)
THD NewsDesk, New Delhi: After a national monitoring survey peer-reviewed showed worrying trends of the non-communicable diseases (NCDs) and related...
Latest Post
India Vaccinates Over 1 Million People in a single day for the first time.
THD NewsDesk, New Delhi: On Thursday, India hit an important milestone, vaccinating over a million people in a single day...
Serum Institute of India writes to PMO recommending reforms in drug regulatory system
THD NewsDesk, New Delhi: Serum Institute of India (SII); the world's largest vaccine manufacturer has written to the Prime Minister's...
24*7 availability of Covid-19 Vaccine jab without any time constraint, says Health Minister.
THD NewsDesk, New Delhi: The government has said that to speed up the vaccination drive so that more and more...
Infosys, Accenture to cover Covid-19 vaccination costs for Indian employees and immediate family
THD NewsDesk, New Delhi: On Wednesday, Information Technology major Infosys Ltd and consulting and outsourcing services provider Accenture PLC, Bengaluru...
Long Covid Syndrome: Its High time we talk about the elephant in the room
TED Guest Coloumn, New Delhi: On 24th February, the WHO drew attention to the post-Covid-19 syndrome that many people suffer...
More than 4,000 poultry birds die of Ranikhet disease in Peddapalli, Telangana
THD NewsDesk, New Delhi: More than 4,000 birds in a poultry farm in Kalwasrirampur mandal died within a span of...
Centre: More Private Hospitals from States and UT to be made vaccination sites.
THD NewsDesk, New Delhi: Amidst the ongoing second phase of Covid vaccination drive, where senior citizens and people above 45...
People allergic to Pfizer or Moderna vaccine to get J&J Covid vaccine, says CDC
THD NewsDesk, New Delhi: The current recommendation made by CDC says that people who have a severe allergic reaction to...
Nulibry looking towards making treatment for Molybdenum Cofactor Deficiency
THD NewsDesk, New Delhi: BridgeBio Pharma and Origin Biosciences’ Nulibry (fosdenopterin) is making the first authorized treatment to reduce the...
